ARCHIVES

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

This article is from The Cancer Letter archive.

Vol. 25 No. 03 | January 22, 1999

Download PDF Visit The Full Archive

Related Articles

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

NCI Cancer Prevention Fellowship Program

April 28, 2000

ASCO Study Predicts Shortage of Oncologists.

March 23, 2007